Position in INVA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$21,069,768
+$4,425,396 QoQ
Shares Held
904,282
+8.6% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.76684706761829.ToString("F0")%
None 2.2331529323817128.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. INVA ranks #39 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,069,768 | 904,282 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $16,644,372 | 832,635 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $13,971,579 | 765,566 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $14,812,776 | 737,321 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $14,917,524 | 822,809 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $18,250,098 | 1,051,879 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $28,014,192 | 1,450,761 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $25,627,163 | 1,562,632 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,254,778 | 1,263,437 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $18,525,749 | 1,154,972 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,599,092 | 661,978 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,431,227 | 426,648 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,536,089 | 492,097 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,449,944 | 562,260 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,256,034 | 538,849 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,961,235 | 1,216,886 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $25,316,125 | 1,308,327 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,014,608 | 638,528 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,703,108 | 460,988 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,198,191 | 2,251,916 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $29,503,103 | 2,468,879 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $31,229,811 | 2,520,566 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $24,548,251 | 2,349,115 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $19,244,992 | 1,376,609 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,635,777 | 1,499,641 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||